Order of IOP measurement affects results

Article

Intraocular pressure (IOP) is higher in the first eye that is measured, according to research published in Archives of Ophthalmology.

Intraocular pressure (IOP) is higher in the first eye that is measured, according to research published in Archives of Ophthalmology.

Dr Melike Pekmezci et al., Department of Ophthalmology, University of California, San Francisco, USA, conducted a study on 105 healthy participants who were randomized into 2 groups. Group 1 underwent 3 sets of 2 IOP measurements for each eye, starting with the right eye. The order of measurements was reversed for group 2. To determine the association of IOP measurement with the order measured a mixed-model, repeated-measures analysis of variance was used. This involved measurement between the first and second eyes, between the first and second visits, between the right and left eyes and with ocular squeezing.

Overall, measurements of IOP decline between first and second visits. IOP measurements were always higher in the initial eye measured, regardless of whether the right or left eye was measured first.

The results suggested that higher IOP measurements was linked to moderate and severe ocular squeezing. It is advised that multiple IOP measurements at multiple visits are crucial in the accurate diagnosis of glaucoma and ocular hypertension patients.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.